Latest Period
Q4 2025
CUSIP: 59267L107
Latest Period
Q4 2025
Institutions Reporting
1
Shares (Excl. Options)
8
Price
$70.50
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
Latest holder context comes from 1 institution filings for Q4 2025.
What is CUSIP 59267L107?
CUSIP 59267L107 identifies MTSR - METSERA, INC. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 59267L107:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Validae Health, L.P. | 12% | $346,544,669 | 13,136,644 | Christopher Whitten Bernard | 31 Mar 2025 | |||
| VANGUARD GROUP INC | 5.5% | $304,823,049 | 5,824,993 | The Vanguard Group | 30 Sep 2025 | |||
| JANUS HENDERSON GROUP PLC | 3.1% | -40% | $228,620,854 | -$148,748,091 | 3,242,849 | -39% | JANUS HENDERSON GROUP PLC | 31 Dec 2025 |
As of 31 Dec 2025, 1 institutional investors reported holding 8 shares of METSERA, INC. - Common Stock (MTSR). This represents 0% of the company’s total 104,608,032 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 0 | $0 | -$564 | $70.75 | 0 |
| 2025 Q4 | 8 | $564 | -$3,388,074,231 | $70.50 | 1 |
| 2025 Q3 | 64,760,626 | $3,388,897,067 | +$398,027,459 | $52.33 | 153 |
| 2025 Q2 | 61,110,674 | $1,738,613,325 | +$190,248,205 | $28.45 | 107 |
| 2025 Q1 | 54,515,246 | $1,486,157,710 | +$1,485,323,689 | $27.22 | 79 |